Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DZUVEO 30 MICROGRAMOS COMPRIMIDO SUBLINGUAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/DZUVEO 30 MICROGRAMOS COMPRIMIDO SUBLINGUAL

Approved

STANDARD

DZUVEO 30 MICROGRAMOS COMPRIMIDO SUBLINGUAL

Laboratoire Aguettant🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 11, 2022
Approval ID: 888d3476b4ce6f5b
Company: Laboratoire Aguettant
Type: Standard

Approval Details

Approval Id: 888d3476b4ce6f5b
Drug Cima Aemps Name: DZUVEO 30 MICROGRAMOS COMPRIMIDO SUBLINGUAL
Register Number: 1181284001
Holder Company Name: Laboratoire Aguettant
Marketing Company Name: Aguettant Iberica S.L.
Holder Company Detail Path: /organization/laboratoire-aguettant
Authorization Date: 2022-11-11
Dosage Form: COMPRIMIDO SUBLINGUAL
Dose: 30 MICROGRAMOS
Route Of Administration: VÍA SUBLINGUAL
Prescription Type: Uso Hospitalario. Estupefacientes
Commercialized: Yes
Company Name: Laboratoire Aguettant
Company Detail Path: /organization/laboratoire-aguettant

Company Information

Pharmaceutical Company Name: Laboratoire Aguettant
Country Name: Belgium
City Name: unknown,country_be
Address: Unknown Belgian address
Website: https://www.aguettant.co.uk

Active Ingredients

SUFENTANILO CITRATO

0,045 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 11, 2022

Approval ID

888d3476b4ce6f5b

Type

Standard

Back to CIMA-AEMPS Approvals